Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Larena M, Prow NA, Hall RA, Petrovsky N, Lobigs M.

J Virol. 2013 Apr;87(8):4395-402. doi: 10.1128/JVI.03144-12. Epub 2013 Feb 6.

2.
3.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.

J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3.

4.

Memory B cells: a proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine.

Konishi E.

Expert Rev Vaccines. 2013 Aug;12(8):871-3. doi: 10.1586/14760584.2013.814828. Epub 2013 Aug 14.

PMID:
23944374
5.

Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.

Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.

Vaccine. 2008 Oct 16;26(44):5590-4. doi: 10.1016/j.vaccine.2008.07.104. Epub 2008 Aug 30.

PMID:
18761388
6.

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.

Cao L, Fu S, Gao X, Li M, Cui S, Li X, Cao Y, Lei W, Lu Z, He Y, Wang H, Yan J, Gao GF, Liang G.

PLoS Negl Trop Dis. 2016 May 3;10(5):e0004686. doi: 10.1371/journal.pntd.0004686. eCollection 2016 May.

7.

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.

Bielefeldt-Ohmann H, Prow NA, Wang W, Tan CS, Coyle M, Douma A, Hobson-Peters J, Kidd L, Hall RA, Petrovsky N.

Vet Res. 2014 Dec 17;45:130. doi: 10.1186/s13567-014-0130-7.

8.

Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.

Okamoto S, Yoshii H, Matsuura M, Kojima A, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y.

Clin Vaccine Immunol. 2012 Jan;19(1):17-22. doi: 10.1128/CVI.05412-11. Epub 2011 Nov 16.

9.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

PMID:
14551893
10.

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.

Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S.

Vaccine. 2011 Aug 11;29(35):5925-31. doi: 10.1016/j.vaccine.2011.06.062. Epub 2011 Jun 30.

PMID:
21723353
11.

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.

Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.

12.

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.

Honda-Okubo Y, Ong CH, Petrovsky N.

Vaccine. 2015 Sep 11;33(38):4892-900. doi: 10.1016/j.vaccine.2015.07.051. Epub 2015 Jul 29.

13.

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.

Paulke-Korinek M, Kollaritsch H, Kundi M, Zwazl I, Seidl-Friedrich C, Jelinek T.

Vaccine. 2015 Jul 9;33(30):3600-4. doi: 10.1016/j.vaccine.2015.05.037. Epub 2015 May 30.

PMID:
26036947
15.

A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus.

Chen HW, Huang HW, Hu HM, Chung HH, Wu SH, Chong P, Tao MH, Pan CH.

J Gen Virol. 2014 Sep;95(Pt 9):1983-90. doi: 10.1099/vir.0.067280-0. Epub 2014 Jun 9.

PMID:
24914069
16.

Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.

Li Y, Counor D, Lu P, Duong V, Yu Y, Deubel V.

Virol J. 2012 Jul 24;9:135. doi: 10.1186/1743-422X-9-135.

17.
18.

A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.

Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A.

Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6.

19.

T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.

Aihara H, Takasaki T, Toyosaki-Maeda T, Suzuki R, Okuno Y, Kurane I.

Viral Immunol. 2000;13(2):179-86.

PMID:
10892998
20.

Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice.

Kulkarni R, Sapkal G, Gore M.

Virus Res. 2012 Dec;170(1-2):118-25. doi: 10.1016/j.virusres.2012.09.006. Epub 2012 Sep 21.

PMID:
23007095

Supplemental Content

Support Center